Fundraising Fox

Bioceptive

New Orleans, US · Founded 2011 · 2 known investors

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

Founders & leadership

SK
Shuchi KhuranaNamed on SEC filing
BC
Benjamin CappielloNamed on SEC filing
JH
John HardmanNamed on SEC filing
SD
Stewart DavisNamed on SEC filing

Board

JN
Joan NeuschelerBoard director
JL
Joseph LovettBoard director
AK
Amit Kumar RathiBoard director
OL
Orin LevyBoard director
VB
Vicki BriggsChair of the Board

Investors · 2

Reported raises · per SEC filings

Form D private placements

$456.4K disclosed across 2 rounds · 2012–2016

$416.4KraisedJan 2016 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joan NeuschelerDirector
  • Joseph LovettDirector
  • Amit Kumar RathiDirector
  • Orin LevyDirector
  • Shuchi KhuranaExecutive Officer
  • Benjamin CappielloExecutive Officer, Director
Offering amount
$650K
Amount sold
$416.4K
First sale
Jan 2016
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$40KraisedMar 2012 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin CappielloExecutive Officer, Director
  • John HardmanDirector
  • Stewart DavisExecutive Officer, Director
Offering amount
$250K
Amount sold
$40K
First sale
Mar 2012
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Bioceptive do?
Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.
Who are Bioceptive's investors?
Bioceptive's investors include Louisiana Funds, New Orleans Startup Fund.
How much funding has Bioceptive raised?
Bioceptive has disclosed $456.4K raised across 2 rounds.
Where is Bioceptive headquartered?
Bioceptive is headquartered in New Orleans, US.